enow.com Web Search

  1. Ad

    related to: vascepa indication fda reviews and complaints phone number search

Search results

  1. Results from the WOW.Com Content Network
  2. Ethyl eicosapentaenoic acid - Wikipedia

    en.wikipedia.org/wiki/Ethyl_eicosapentaenoic_acid

    Ethyl eicosapentaenoic acid (E-EPA, icosapent ethyl), sold under the brand name Vascepa among others, is a medication used to treat dyslipidemia [4] and hypertriglyceridemia. [3] It is used in combination with changes in diet in adults with hypertriglyceridemia ≥ 150 mg/dL. Further, it is often required to be used with a statin (maximally ...

  3. Amarin Corporation - Wikipedia

    en.wikipedia.org/wiki/Amarin_Corporation

    Amarin Corporation. Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. [1] The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.

  4. 3 Lessons From Amarin's Failures in 2013 - AOL

    www.aol.com/2013/12/05/3-lessons-from-amarins...

    For premium support please call: 800-290-4726 more ways to reach us

  5. Omega-3 acid ethyl esters - Wikipedia

    en.wikipedia.org/wiki/Omega-3_acid_ethyl_esters

    Omega-3 acid ethyl esters are used in addition to changes in diet to reduce triglyceride levels in adults with severe (≥ 500 mg/dL) hypertriglyceridemia. [10] In the European Union and other major markets outside the US, omega-3 acid ethyl esters are indicated for hypertriglyceridemia by itself, or in combination with a statin for people with mixed dyslipidemia.

  6. Amarin's Vascepa MAA for Heart Risk Indication Accepted in EU

    www.aol.com/news/amarins-vascepa-maa-heart-risk...

    For premium support please call: 800-290-4726 more ways to reach us

  7. Amarin Rises on Priority Review for Vascepa Label Expansion - AOL

    www.aol.com/news/amarin-rises-priority-review...

    For premium support please call: 800-290-4726 more ways to reach us

  8. Amarin (AMRN) Gets FDA Panel Nod for Vascepa Label ... - AOL

    www.aol.com/news/amarin-amrn-gets-fda-panel...

    For premium support please call: 800-290-4726 more ways to reach us

  9. Approved Drug Products with Therapeutic Equivalence ...

    en.wikipedia.org/wiki/Approved_Drug_Products...

    Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the Orange Book, is a publication produced by the United States Food and Drug Administration (FDA), as required by the Drug Price and Competition Act (Hatch-Waxman Act). The Hatch-Waxman Act was created to '"strike a balance between two competing policy interests:

  1. Ad

    related to: vascepa indication fda reviews and complaints phone number search